Login / Signup
A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients.
Mohammad I Saleh
Published in:
Clinical pharmacokinetics (2018)
NV15942 and NV15801.
Keyphrases
</>
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
dendritic cells
immune response
recombinant human